EMILY SHUMAKER: Open Payments
NPI 1578037834 · ALEXANDRIA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$726 in 32 payments from 10 companies in 2025. Trend: 2023 $721 · 2024 $777 · 2025 $726
Food & beverage: $726
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $264 |
| ABBVIE INC. | 4 | $101 |
| Lilly USA, LLC | 3 | $66 |
| PFIZER INC. | 3 | $64 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| Amgen Inc. | 2 | $51 |
| Exact Sciences Corporation | 2 | $42 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| Astellas Pharma US Inc | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
Products named: Ozempic, ELIQUIS, Wegovy, QULIPTA, OTEZLA, Rybelsus, UBRELVY, MOUNJARO.
Industry payments across VA — which companies pay providers there.
